HIGH-DOSE METOCLOPRAMIDE IN CISPLATIN TREATED PATIENTS

被引：0
|
作者：
FRUSTACI, S
TIRELLI, U
TUMOLO, S
VERONESI, A
GALLIGIONI, E
TROVO, M
GRIGOLETTO, E
机构：
来源：
CHEMIOTERAPIA | 1983年 / 2卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：75 / 77
页数：3
相关论文
共 50 条
  • [1] EFFICACY OF CONTINUOUS HIGH-DOSE METOCLOPRAMIDE IN PATIENTS RECEIVING DAILY CISPLATIN INFUSIONS
    SAAB, GA
    IBRAHIM, N
    AZOURI, N
    CANCER TREATMENT REPORTS, 1987, 71 (10): : 979 - 980
  • [2] HIGH-DOSE DEXAMETHASONE AND HIGH-DOSE METOCLOPRAMIDE VERSUS HIGH-DOSE DEXAMETHASONE AND SULPIRIDE IN THE MANAGEMENT OF CISPLATIN-INDUCED EMESIS
    ROSENBLATT, E
    LEV, LM
    ROBINSON, E
    ONCOLOGY, 1988, 45 (04) : 297 - 299
  • [3] CLINICAL PHARMACOKINETICS OF HIGH-DOSE METOCLOPRAMIDE IN CANCER-PATIENTS RECEIVING CISPLATIN THERAPY
    MCDERMED, JE
    COHEN, JL
    JOSEPH, C
    STRUM, SB
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (10) : 1400 - 1408
  • [4] ANTIEMETIC EFFECT AND PHARMACOKINETICS OF HIGH-DOSE METOCLOPRAMIDE IN CANCER-PATIENTS TREATED WITH CISPLATIN-CONTAINING CHEMOTHERAPY REGIMENS
    HAVSTEEN, H
    NIELSEN, H
    KJAER, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (01) : 33 - 40
  • [5] RENAL TUBULAR FUNCTION IN PATIENTS TREATED WITH HIGH-DOSE CISPLATIN
    DAUGAARD, G
    ABILDGAARD, U
    HOLSTEINRATHLOU, NH
    BRUUNSHUUS, I
    BUCHER, D
    LEYSSAC, PP
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (02) : 164 - 172
  • [6] HIGH-DOSE METOCLOPRAMIDE AND CHLORPROMAZINE IN THE TREATMENT OF CISPLATIN-INDUCED EMESIS
    AASEBO, U
    SLORDAL, L
    PRYTZ, PS
    AARBAKKE, J
    PHARMACOLOGY & TOXICOLOGY, 1987, 60 (05): : 337 - 339
  • [7] THE BENEFIT AND RISK OF HIGH-DOSE METOCLOPRAMIDE IN COMPARISON TO HIGH-DOSE HALOPERIDOL OR TRIFLUPROMAZINE IN CISPLATIN-INDUCED EMESIS
    SALLER, R
    HELLENBRECHT, D
    KLINISCHE WOCHENSCHRIFT, 1985, 63 (09): : 428 - 432
  • [8] ANTIEMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE AND DEXAMETHASONE IN PATIENTS RECEIVING CISPLATIN CHEMOTHERAPY - A RANDOMIZED TRIAL
    TSAVARIS, N
    TSAROUCHANOUTSOU, E
    BACOYANNIS, C
    MYLONAKIS, N
    VALILIS, P
    KOZATSANIHALIVIDI, D
    TSOUTSOS, H
    DROUFAKOU, S
    KOSMIDIS, P
    ONCOLOGY, 1992, 49 (06) : 479 - 483
  • [9] EFFICACY AND SAFETY OF GRANISETRON COMPARED WITH HIGH-DOSE METOCLOPRAMIDE PLUS DEXAMETHASONE IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN IN A SINGLE-BLIND STUDY
    CHEVALLIER, B
    EUROPEAN JOURNAL OF CANCER, 1990, 26 : S33 - S36
  • [10] BIOAVAILABILITY OF HIGH-DOSE METOCLOPRAMIDE
    TAYLOR, WB
    BATEMAN, DN
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (03) : P296 - P296
12345